SAVA
$9.11
Cassava Sciences
$.04
.44%
SAVA
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.07)
Revenue:  $0.00 Mil
Tuesday
Nov 3
8:15 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SAVA reports earnings?
Beat
Meet
Miss

Where is SAVA's stock price going from here?
Up
Flat
Down
Stock chart of SAVA
Analysts
Summary of analysts' recommendations for SAVA
Score
Grade
Pivots
Resistance
$9.91
$9.67
$9.39

$9.15

Support
$8.87
$8.63
$8.35
Tweet
Growth
Description
Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.